PL436252A1 - Method for protecting products from natural stone and conglomerates of natural stone, in particular granite, and a biocidal mixture for protecting products from natural stone and conglomerates of natural stone, in particular granite - Google Patents
Method for protecting products from natural stone and conglomerates of natural stone, in particular granite, and a biocidal mixture for protecting products from natural stone and conglomerates of natural stone, in particular graniteInfo
- Publication number
- PL436252A1 PL436252A1 PL436252A PL43625220A PL436252A1 PL 436252 A1 PL436252 A1 PL 436252A1 PL 436252 A PL436252 A PL 436252A PL 43625220 A PL43625220 A PL 43625220A PL 436252 A1 PL436252 A1 PL 436252A1
- Authority
- PL
- Poland
- Prior art keywords
- natural stone
- conglomerates
- granite
- protecting products
- particular granite
- Prior art date
Links
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Przedmiotem wynalazku jest sposób zabezpieczania wyrobów z kamienia naturalnego i konglomeratów kamienia naturalnego, zwłaszcza granitu oraz mieszanina biobójcza i antygrzybicza do zabezpieczania wyrobów z kamienia naturalnego i konglomeratów kamienia naturalnego, zwłaszcza granitu. Sposób zabezpieczania wyrobów z kamienia naturalnego i konglomeratów kamienia naturalnego, zwłaszcza granitu, według wynalazku, charakteryzuje się tym, że po ostatnim etapie obróbki powierzchni nanosi się roztwór wodny ditlenku tytanu i chlorku srebra. Na powierzchnię nanosi się od dwie do trzy warstwy. Poszczególne warstwy nanosi się w odstępach dwu do trzech godzin. Przedmiotem zgłoszenia jest także mieszanina biobójcza i antygrzybicza do zabezpieczania wyrobów z kamienia naturalnego i konglomeratów kamienia naturalnego, zwłaszcza granitu, która charakteryzuje się tym, że stanowi ją roztwór wodny ditlenku tytanu i chlorku srebra. Zawartość ditlenku tytanu i chlorku srebra wynosi 0,02 — 0,05%, przy czym ilość ditlenku tytanu wynosi 75 — 85%, zaś ilość chlorku srebra wynosi 15 — 25%.The subject of the invention is a method of protecting natural stone products and natural stone conglomerates, especially granite, and a biocidal and antifungal mixture for the protection of natural stone products and natural stone conglomerates, especially granite. The method of protecting natural stone products and natural stone conglomerates, in particular granite, according to the invention is characterized in that, after the last surface treatment step, an aqueous solution of titanium dioxide and silver chloride is applied. Two to three layers are applied to the surface. The individual layers are applied at intervals of two to three hours. The subject of the application is also a biocidal and antifungal mixture for the protection of natural stone products and natural stone conglomerates, especially granite, characterized by the fact that it is an aqueous solution of titanium dioxide and silver chloride. The content of titanium dioxide and silver chloride is 0.02-0.05%, the amount of titanium dioxide is 75-85%, and the amount of silver chloride is 15-25%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL436252A PL243100B1 (en) | 2020-12-07 | 2020-12-07 | Method for protecting products from natural stone and conglomerates of natural stone, in particular granite, and a biocidal mixture for protecting products from natural stone and conglomerates of natural stone, in particular granite |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL436252A PL243100B1 (en) | 2020-12-07 | 2020-12-07 | Method for protecting products from natural stone and conglomerates of natural stone, in particular granite, and a biocidal mixture for protecting products from natural stone and conglomerates of natural stone, in particular granite |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL436252A1 true PL436252A1 (en) | 2021-09-06 |
| PL243100B1 PL243100B1 (en) | 2023-06-26 |
Family
ID=77662582
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL436252A PL243100B1 (en) | 2020-12-07 | 2020-12-07 | Method for protecting products from natural stone and conglomerates of natural stone, in particular granite, and a biocidal mixture for protecting products from natural stone and conglomerates of natural stone, in particular granite |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL243100B1 (en) |
-
2020
- 2020-12-07 PL PL436252A patent/PL243100B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL243100B1 (en) | 2023-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP21064100A (en) | COMBINATIONS OF ACTIVE COMPOUNDS COMPRISING A (THIO)CARBOXAMIDE DERIVATIVE AND A FUNGICIDE COMPOUND | |
| BRPI0517032A (en) | compounds, process for their manufacture, pharmaceutical compositions comprising them, method for treating and / or preventing diseases and using such compounds | |
| BR112018009577A2 (en) | use of compounds of formula i, compounds, agrochemical composition and method to combat phytopathogenic harmful fungi | |
| EA201991312A1 (en) | COMBINATIONS OF ACTIVE COMPOUNDS | |
| MX2018003331A (en) | Administration of deuterated cftr potentiators. | |
| MX2021013934A (en) | Compounds and methods for the treatment of covid-19. | |
| BRPI0518222A (en) | compound, process for their manufacture, pharmaceutical compositions comprising them, method for treating and / or preventing diseases that are associated with modulating h3 receptors and using them | |
| AR050291A1 (en) | METHOD FOR THE PROTECTION OF USEFUL PLANTS OR PLANT PROPAGATION MATERIALS | |
| NO20072461L (en) | Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity | |
| BRPI0518907A2 (en) | compounds, process for their manufacture, pharmaceutical compositions comprising them, method for the treatment and / or prevention of diseases that are associated with the modulation of h3 receptors and their use | |
| PH12021550324A1 (en) | 5 to 7 membered heterocyclic amides as jak inhibitors | |
| MX2019011506A (en) | Combinations of chk1- and wee1 - inhibitors. | |
| CL2019001041A1 (en) | Therapeutic compounds and methods to use them. | |
| UY36432A (en) | COMBINATIONS OF ACTIVE COMPOUNDS THAT INCLUDE A DERIVATIVE OF (UNCLE) CARBOXAMIDE AND FUNGICIDE COMPOUND (S) | |
| MY142493A (en) | Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, their use as a medicament and medicament comprising them | |
| DE60323942D1 (en) | LIPASE-INHIBITING COMPOSITION | |
| AR106538A1 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOIDOSIS | |
| WO2017020874A3 (en) | Method for treating diseases in plants | |
| ATE420089T1 (en) | SUBSTITUTED AZACHINAZOLINES WITH ANTIVIRAL EFFECT | |
| MX2021005944A (en) | RIP1 Inhibitors. | |
| PL436252A1 (en) | Method for protecting products from natural stone and conglomerates of natural stone, in particular granite, and a biocidal mixture for protecting products from natural stone and conglomerates of natural stone, in particular granite | |
| MX2019012522A (en) | Therapeutic compounds and methods. | |
| ATE441430T1 (en) | FACTOR VIIA OR FACTOR VIIA EQUIVALENT FOR PREVENTING OR ATTENUATION OF HEMORRHAGIA GROWTH AND/OR EDEMA PRODUCTION AFTER INTRACEREBRAL HEMORRHAGIA (I) | |
| DE602006020838D1 (en) | MEDICAMENTS FOR PREVENTING OR TREATING HEART FAILURE WITH AN ANTICHOLINERGICUM | |
| MX2016008968A (en) | Organic compounds. |